Review of intravenous selenium infusions for the critically ill patient

Rebecca J. Haygood, Roland Dickerson, Rex Brown

Research output: Contribution to journalReview article

Abstract

Attempts to improve mortality for patients with sepsis, severe sepsis, systemic inflammatory response syndrome, and septic shock continue to challenge health care professionals. This review will explore how the antioxidant, and possibly pro-oxidant, properties of selenium may benefit critically ill patients. Literature examining improvements in clinical outcomes from intravenous (IV) selenium infusion therapy will be discussed. Although there is not an overwhelming amount of knowledge about IV selenium and its effect on morbidity and mortality, this review will outline recent research evaluating the use of IV selenium infusions and its potential to decrease morbidity and mortality for different critically ill patient populations.

Original languageEnglish (US)
Pages (from-to)933-938
Number of pages6
JournalHospital Pharmacy
Volume47
Issue number12
DOIs
StatePublished - Dec 1 2012

Fingerprint

Selenium
Intravenous Infusions
Critical Illness
Mortality
Sepsis
Morbidity
Systemic Inflammatory Response Syndrome
Septic Shock
Health care
Reactive Oxygen Species
Antioxidants
Delivery of Health Care
Research
Population
Therapeutics

All Science Journal Classification (ASJC) codes

  • Pharmacology
  • Pharmacology (medical)
  • Pharmacy

Cite this

Review of intravenous selenium infusions for the critically ill patient. / Haygood, Rebecca J.; Dickerson, Roland; Brown, Rex.

In: Hospital Pharmacy, Vol. 47, No. 12, 01.12.2012, p. 933-938.

Research output: Contribution to journalReview article

Haygood, Rebecca J. ; Dickerson, Roland ; Brown, Rex. / Review of intravenous selenium infusions for the critically ill patient. In: Hospital Pharmacy. 2012 ; Vol. 47, No. 12. pp. 933-938.
@article{c32327da37a2451bbdd6543b92f7fc85,
title = "Review of intravenous selenium infusions for the critically ill patient",
abstract = "Attempts to improve mortality for patients with sepsis, severe sepsis, systemic inflammatory response syndrome, and septic shock continue to challenge health care professionals. This review will explore how the antioxidant, and possibly pro-oxidant, properties of selenium may benefit critically ill patients. Literature examining improvements in clinical outcomes from intravenous (IV) selenium infusion therapy will be discussed. Although there is not an overwhelming amount of knowledge about IV selenium and its effect on morbidity and mortality, this review will outline recent research evaluating the use of IV selenium infusions and its potential to decrease morbidity and mortality for different critically ill patient populations.",
author = "Haygood, {Rebecca J.} and Roland Dickerson and Rex Brown",
year = "2012",
month = "12",
day = "1",
doi = "10.1310/hpj4712-933",
language = "English (US)",
volume = "47",
pages = "933--938",
journal = "Hospital Pharmacy",
issn = "0018-5787",
publisher = "Facts and Comparisons",
number = "12",

}

TY - JOUR

T1 - Review of intravenous selenium infusions for the critically ill patient

AU - Haygood, Rebecca J.

AU - Dickerson, Roland

AU - Brown, Rex

PY - 2012/12/1

Y1 - 2012/12/1

N2 - Attempts to improve mortality for patients with sepsis, severe sepsis, systemic inflammatory response syndrome, and septic shock continue to challenge health care professionals. This review will explore how the antioxidant, and possibly pro-oxidant, properties of selenium may benefit critically ill patients. Literature examining improvements in clinical outcomes from intravenous (IV) selenium infusion therapy will be discussed. Although there is not an overwhelming amount of knowledge about IV selenium and its effect on morbidity and mortality, this review will outline recent research evaluating the use of IV selenium infusions and its potential to decrease morbidity and mortality for different critically ill patient populations.

AB - Attempts to improve mortality for patients with sepsis, severe sepsis, systemic inflammatory response syndrome, and septic shock continue to challenge health care professionals. This review will explore how the antioxidant, and possibly pro-oxidant, properties of selenium may benefit critically ill patients. Literature examining improvements in clinical outcomes from intravenous (IV) selenium infusion therapy will be discussed. Although there is not an overwhelming amount of knowledge about IV selenium and its effect on morbidity and mortality, this review will outline recent research evaluating the use of IV selenium infusions and its potential to decrease morbidity and mortality for different critically ill patient populations.

UR - http://www.scopus.com/inward/record.url?scp=84871314024&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84871314024&partnerID=8YFLogxK

U2 - 10.1310/hpj4712-933

DO - 10.1310/hpj4712-933

M3 - Review article

VL - 47

SP - 933

EP - 938

JO - Hospital Pharmacy

JF - Hospital Pharmacy

SN - 0018-5787

IS - 12

ER -